Nuclear imaging in cardiac resynchronization therapy.

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Cardiac resynchronization therapy (CRT) treats severe heart failure, but 20-30% of patients do not respond.
• Left ventricular (LV) dyssynchrony is crucial for CRT response.
• Nuclear imaging offers methods to assess cardiac function and tissue viability.

Purpose of the Study:

• To review the role of nuclear imaging in selecting heart failure patients for CRT.
• To discuss how imaging techniques predict CRT response.
• To evaluate the value of various imaging modalities in CRT patient selection.

Main Methods:

• Gated myocardial perfusion SPECT with phase analysis for LV dyssynchrony.
• SPECT to assess scar tissue and myocardial viability.
• PET studies for myocardial perfusion, metabolism, and efficiency changes post-CRT.

Main Results:

• LV dyssynchrony is mandatory for CRT response.
• Extensive scar tissue limits CRT effectiveness.
• Viable tissue in the LV pacing lead target zone is necessary for CRT success.

Conclusions:

• Nuclear imaging, including SPECT and PET, plays a significant role in selecting heart failure patients for CRT.
• Assessing LV dyssynchrony and myocardial viability with nuclear imaging can optimize CRT outcomes.
• Further integration of advanced imaging techniques can improve patient selection and treatment efficacy for CRT.